Hitachi, Ltd. (Executive President and CEO: Toshihiro Minato / hereinafter referred to as Hitachi) announced on April 18 that it has recently been from Wan Xuan International, a subsidiary of Hong Kong Sanatorium & Hospital. Million Hope International Limited) has received an order for the first proton therapy cancer treatment system in the Hong Kong Special Administrative Region, including a 10-year system operation and maintenance service. Hitachi will install a proton therapy system equipped with two scanning rack treatment rooms equipped with spot scanning illumination technology at the Honghe Yanghe Hospital's Yanghe East Medical Center. In order to meet the area limitation of urban land use, the proton therapy system adopts a compact structure design with an accelerator and multiple treatment rooms. This will be a reference case for setting up a proton therapy system in a crowded city center in the future. . The system is expected to be officially put into use as soon as 2020. This is the first time Hitachi has provided a proton cancer treatment system for Hong Kong. Established in 1922, Hong Kong Yanghe Hospital is a large private general hospital with a medical level known in Asia. Its advanced medical technology, high-quality care services, and patient-centered healthcare concepts are leading the way. The new Proton Line Medical Center will be located in Yanghe East District, and the new building will be 17 stories high. The Hitachi Proton Line Cancer Treatment System will be installed in the underground space. In December 2007, Hitachi's proton-line cancer treatment system with spot-scanning technology received the world's first proton-line cancer treatment system license from the US Food and Drug Administration (FDA), and in 2008 In May, it was introduced to the US Anderson Cancer Center, a large-scale cancer treatment center in the world. Later, it was provided to the Nagoya Proton Line Treatment Center in Japan (September 2013) and Hokkaido University (March 2014). In FY2015, the Hitachi Proton Line Cancer Treatment System, which has been installed in three facilities in the United States, has been put into use. To date, Hitachi's proton-line cancer treatment system has treated more than 10,000 patients. The system's high start-up rate and Hitachi's long-term and substantial support system for its customers are highly reliable and performance-recognized worldwide. Widely recognized within the scope. Mr. Li Weiwen, who is also the manager of the Hong Kong Yanghe Hospital (Administration) and Wanxuan International, said: "The Hitachi Proton Cancer Treatment System has a wealth of experience in the installation of multiple treatment facilities in Japan and the United States. This will enable patients in this area to enjoy lower-priority, more advanced cancer treatment options. Our hospital is committed to 'quality service excellence care' and hopes to bring the most advanced treatment equipment to patients. We are very happy to cooperate with Hitachi. I look forward to introducing the proton therapy system to Hong Kong as soon as possible." "The Hong Kong Yanghe Hospital has always insisted on introducing advanced medical technology and equipment to provide patients with high-quality medical services. Hitachi is honored to receive technical recognition from the hospital, and is also the CEO of Hitachi's executive health care business unit. The hospital provides a proton cancer treatment system. Although the area of ​​the Yanghe Medical Center is limited in the center of the city, Hitachi has also made a system plan to provide high-quality proton cancer treatment. We believe this and Hong Kong Yanghe Hospital The cooperation will surely become an advanced case of proton cancer treatment in Asia." In the future, Hitachi will accelerate the promotion of the proton-line cancer treatment system worldwide and contribute to the world's cancer treatment while continuing to expand its medical and health care business. Kn95 5 Layers Mask,Kn95 Filters Face Mask,Kn95 5 Layers Cup Facemask,Kn95 5 Layers Fold Flat Facemask Jiangmen anjian biotechnology co. LTD , https://www.jmanjianmask.com